Localized adiposity. Localized adiposity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Overweight Women aged between 18 to 65 years; no use of certain drug like the drugs that Reduce sensitivity local steroid neuro drugs in the past six months; no medical history of Cardiovascular disease and Diabetes; not be pregnant and Breastfeeding; BMI between 25 to 30 kg/m2; Not having Cardiac pacemaker. Exclusion criteria: Pregnancy and Lactation; Age under 18 years or above 65 years; Male gender; Skin infection; Skin sensitivity to sunlight; use of topical steroids; Not being agree to continue working; People with type 1 and type 2 Diabetes; Systemic disease; not having weight reduction diet in the past three months; Having Cardiac pacemaker; BMI over 30 kg/m2 and less than 25 kg/m2
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Before starting intervention, during the intervention, at the end of period of intervention. Method of measurement: Tanita body composition analyzer.;Waist circumference. Timepoint: Before starting intervention, during the intervention, at the end of period of intervention. Method of measurement: Non elastic meter in terms of centimeter.;Abdominal circumference. Timepoint: Before starting intervention, during the intervention, at the end of period of intervention. Method of measurement: Non elastic meter in terms of centimeter.;Hip circumference. Timepoint: Before starting intervention, during the intervention, at the end of period of intervention. Method of measurement: Non elastic meter in terms of centimeter.;Waist to Hip circumference. Timepoint: Before starting intervention, during the intervention, at the end of period of intervention. Method of measurement: Non elastic meter in terms of centimeter.;Totall cholesterol. Timepoint: Before starting intervention, at the end of period of intervention. Method of measurement: Spectrophotometric.;Improvement of Cellulite. Timepoint: Before starting intervention, at the end of period of intervention. Method of measurement: Nurnberger- Muller score.;Blood pressure. Timepoint: Before starting intervention, at the end of period of intervention. Method of measurement: Sphygmomanometer.;LDL-C. Timepoint: Before starting intervention, at the end of period of intervention. Method of measurement: Spectrophotometric.;HDL-C. Timepoint: Before starting intervention, at the end of period of intervention. Method of measurement: Spectrophotometric.;TG. Timepoint: Before starting intervention, at the end of period of intervention. Method of measurement: Spectrophotometric.;Fasting Blood Sugar (FBS). Timepoint: Before starting intervention, at the end of period of intervention. Method of measurement: Spectrophotometric.;Pro oxidant Antioxidant Balance. Timepoint: Before starting intervention, at the end of peri | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences